CLINUVEL recruits 200 patients in Phase III vitiligo trial CUV105 2025 Announcements . Clinical . News 07.05.2025
Appendix 3G – Notification regarding unquoted securities 2025 Announcements . Financial . News . Regulatory 23.04.2025
Appendix 3H – Notification of cessation of securities 2025 Announcements . Financial . News . Regulatory 09.04.2025
Appendix 2A – Application for quotation of securities 2025 Announcements . Financial . News . Regulatory 07.04.2025
Appendix 2A – Application for quotation of securities 2025 Announcements . Financial . News . Regulatory 07.04.2025
Appendix 3C – Final buy-back notification 2025 Announcements . Financial . News . Regulatory 27.03.2025